Home/Filings/3/0001104659-23-080865
3//SEC Filing

Fairmount Healthcare Fund L.P. 3

Accession 0001104659-23-080865

CIK 0001974640other

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 6:39 PM ET

Size

25.3 KB

Accession

0001104659-23-080865

Insider Transaction Report

Form 3
Period: 2023-07-13
Holdings
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund II LP)
    Exercise: $0.00Common Stock (6,521,895 underlying)
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund LP)
    Exercise: $0.00Common Stock (221,426 underlying)
Holdings
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund LP)
    Exercise: $0.00Common Stock (221,426 underlying)
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund II LP)
    Exercise: $0.00Common Stock (6,521,895 underlying)
Holdings
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund LP)
    Exercise: $0.00Common Stock (221,426 underlying)
  • Non-Voting Common Stock

    (indirect: By Fairmount Healthcare Fund II LP)
    Exercise: $0.00Common Stock (6,521,895 underlying)
Footnotes (3)
  • [F1]The Non-Voting Common Stock have no expiration date and are convertible in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation at any time at the option of the holder into common stock of the Issuer ("Common Stock") on a 1-for-1 basis without consideration to the extent that after giving effect to such conversion the holders thereof, together with their affiliates and any members of a Section 13(d) group with such holders, would beneficially own, for purposes of Rule 13d-3 under the Securities Act of 1934, as amended, no more than 9.99% of the outstanding shares of Common Stock immediately prior to and following such conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer, provided that the percentage may not exceed 19.99%.
  • [F2]Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the shares of Non-Voting Common Stock held by Fairmount Healthcare Fund LP ("Fund I"). Peter Harwin and Tomas Kiselak are the Managing Members of Fairmount Healthcare Fund GP LLC. Fairmount Funds Management LLC, Fairmount Healthcare Fund GP LLC, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
  • [F3]Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Non-Voting Common Stock held by Fairmount Healthcare Fund II LP ("Fund II"). Peter Harwin and Tomas Kiselak are the Managing Members of Fairmount Healthcare Fund II GP LLC. Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Issuer

Apogee Therapeutics, Inc.

CIK 0001974640

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001686157

Filing Metadata

Form type
3
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 6:39 PM ET
Size
25.3 KB